P21 is a synthetic small-molecule peptide analog extensively used in pre-clinical research to investigate CNTF-like neurotrophic effects, brain-derived neurotrophic factor (BDNF) upregulation, tau hyperphosphorylation inhibition, and adult hippocampal neurogenesis. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications.
Engineered solely for preclinical investigations, each batch of P21 undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification.
Scientific Overview
P21 functions as a CNTF-derived mimetic that influences neurotrophic pathways without the immunogenicity or side effects of full-length CNTF in research settings. Preclinical investigations demonstrate P21’s potential effects in the following areas:
- Enhancement of dentate gyrus neurogenesis and maturation of newborn neurons
- Upregulation of BDNF expression and synaptic plasticity markers
- Modulation of GSK-3β activity to reduce tau hyperphosphorylation
- Investigation of cognitive and mnemonic endpoints in preclinical rodent models
- Influence on neuronal survival and dendritic/synaptic integrity in disease models
Why Researchers Choose Our P21
For laboratories requiring dependable P21 research peptide, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:
- Purity and structural identity
- Consistent performance in research applications
- Rigorous production controls and full documentation
- Accessible pricing within the research community
Research-Referenced Functional Attributes (Based on existing preclinical and literature data—not intended as claims of therapeutic use)
- Promotion of neurogenesis and maturation in the dentate gyrus granular and subgranular zones in rodent models
- Increase in BDNF levels leading to synaptic protein expression enhancement
- Inhibition of tau hyperphosphorylation through GSK-3β pathway modulation
- Support for investigations into cognitive and neuronal plasticity endpoints in preclinical models
- Potential rescue of synaptic deficits in transgenic neurodegeneration models
- Examination of oral bioavailability and blood-brain barrier permeability in long-term studies
For Research Use Only. Not for human use.
